Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice
Open Access
- 1 October 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 315 (1) , 240-247
Abstract
The strategic localization of peptide transporter 2 (PEPT2), a proton-coupled oligopeptide transporter, to the apical membrane of epithelial cells in the kidney and choroid plexus suggests that it plays an important role in the disposition of peptides/mimetics in the body. Therefore, the in vivo significance of PEPT2 was investigated in wild-type and PEPT2 null mice following an i.v. bolus dose (0.05 μmol/g body weight) of [14C]glycylsarcosine (GlySar). In PEPT2 null mice, the clearance (total and renal) of GlySar was markedly increased (2-fold), resulting in concomitantly lower systemic concentrations. In addition, renal reabsorption was almost abolished, and GlySar was eliminated by glomerular filtration. Of the 46% of GlySar reabsorbed in wild-type mice, PEPT2 accounted for 86% and PEPT1 accounted for 14% of reabsorbed substrate. Analysis of GlySar uptake in kidney sections revealed that PEPT2 was primarily localized in the outer medullary region. Wild-type mice also had greater choroid plexus concentrations of GlySar and a 5-fold greater choroid plexus/cerebrospinal fluid (CSF) ratio as compared with null mice at 60 min. Null mice exhibited a greater CSF/blood ratio at 60 min (0.9 versus 0.2) and area under the curve (AUC)CSF/AUCblood ratio over 60 min (0.45 versus 0.12), indicating that PEPT2 significantly reduces the exposure of GlySar in CSF. Our in vivo results demonstrate that PEPT2 is the predominant peptide transporter in kidney and that it acts as an efflux transporter in choroid plexus. Thus, PEPT2 may have profound effects on the sensitivity and/or toxicity of peptides and peptide-like drugs.Keywords
This publication has 34 references indexed in Scilit:
- The proton oligopeptide cotransporter family SLC15 in physiology and pharmacologyPflügers Archiv - European Journal of Physiology, 2004
- Effects of Organic Anion, Organic Cation, and Dipeptide Transport Inhibitors on Cefdinir in the Isolated Perfused Rat KidneyAntimicrobial Agents and Chemotherapy, 2003
- Transport of 5-aminolevulinic acid between blood and brainBrain Research, 2003
- Distribution of peptide transporter PEPT2 mRNA in the rat nervous systemBrain Structure and Function, 1999
- Function and Molecular Structure of Brush Border Membrane Peptide/H+ SymportersThe Journal of Membrane Biology, 1996
- Peptide Transporters in the Intestine and the KidneyAnnual Review of Nutrition, 1996
- Identification of a renal cell line that constitutively expresses the kidney‐sp ecific high‐affinity H + /peptide cotransporterThe FASEB Journal, 1995
- Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidneyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Uptake and metabolism of dipeptides by human red blood cellsBiochemical Journal, 1990
- Effect of Plasma Protein Binding on Renal Clearance of DrugsJournal of Pharmaceutical Sciences, 1980